Somatic Mitochondrial DNA Point Mutations Used as Biomarkers to Demonstrate Genomic Heterogeneity in Primary Prostate Cancer
Open Access
- 28 August 2020
- journal article
- research article
- Published by Hindawi Limited in Prostate Cancer
- Vol. 2020, 1-10
Abstract
Primary prostate tumor heterogeneity is poorly understood, leaving research efforts with challenges regarding the initiation and advancement of the disease. The growth of tumor cells is accompanied by mutations in nuclear and in mitochondrial genomes. Thus, mitochondrial DNA mutations may be used as tumor cell markers. By the use of laser capture microdissection coupled with assays for mitochondrial point mutation detection, mtDNA mutations were used to trace mutated cells at a histological level. Point mutations in mtDNA were determined in 12 primary prostate cancers. The tumors represent different pathology-prognostic grade groups. Known mutational hotspots of the mtDNA were scanned for heteroplasmy. All specimens with mtDNA heteroplasmy were subsequently subsampled by laser capture microdissection. From a total number of 1728 microsamples, mitochondrial DNA target sequences were amplified and base substitutions detected by cycling temperature capillary electrophoresis. Real-time PCR was used as a quantitative assay to determine the relative mtDNA copy number of 12 tumors studied, represented by two samples from each (N = 24); a high degree (75%) demonstrated tumor specimen heterogeneity. A grid of 96 spots isolated by laser capture microdissection demonstrated interfocal sample heterogeneity and increased the limit of detection. The spots demonstrated a wide range of mutant fractions from 0 to 100% mutant copies. The mitochondrial DNA copy number in the samples was determined by real-time PCR. No correlation between copy number and pathology-prognostic grade groups was observed. Somatic mitochondrial DNA point mutations represent traceable biomarkers demonstrating heterogeneity in primary prostate cancer. Mutations can be detected in areas before changes in tissue histopathology are evident to the pathologist.Keywords
Funding Information
- “Torsteds Legater”
This publication has 42 references indexed in Scilit:
- The Mitochondrial and Autosomal Mutation Landscapes of Prostate CancerEuropean Urology, 2013
- Correlation between increased copy number of mitochondrial DNA and clinicopathological stage in colorectal cancerOncology Letters, 2011
- Heteroplasmic mitochondrial DNA mutations in normal and tumour cellsNature, 2010
- Tumor heterogeneity: Causes and consequencesBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2010
- A Methodological Approach to Tracing Cell Lineage in Human Epithelial TissuesStem Cells, 2009
- Fetal–juvenile origins of point mutations in the adult human tracheal–bronchial epithelium: Absence of detectable effects of age, gender or smoking statusMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2008
- Analysis of mutational spectra by denaturing capillary electrophoresisNature Protocols, 2008
- Technology to accelerate pangenomic scanning for unknown point mutations in exonic sequences: cycling temperature capillary electrophoresis (CTCE)BMC Genomic Data, 2007
- Somatic Mitochondrial DNA Mutations in Prostate Cancer and Normal Appearing Adjacent Glands in Comparison to Age-Matched Prostate Samples without Malignant HistologyThe Journal of Molecular Diagnostics, 2006
- Separation of transforming amino acid-substituting mutations in codons 12, 13 and 61 of the N-ras gene by constant denaturant capillary electrophoresis (CDCE)Carcinogenesis, 1995